Hantz Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Buy
2,052
+555
+37% +$206K 0.01% 577
2026
Q1
$438K Buy
1,497
+433
+41% +$142K 0.01% 691
2025
Q4
$373K Buy
1,064
+347
+48% +$117K 0.01% 668
2025
Q3
$232K Buy
717
+440
+159% +$137K ﹤0.01% 698
2025
Q2
$108K Buy
277
+149
+116% +$59.9K ﹤0.01% 745
2025
Q1
$56K Buy
+128
New +$51.4K ﹤0.01% 686

Other funds holding ELV

Hantz Financial Services's ELV Position: Q2 2026 in Review

Hantz Financial Services increased its Elevance Health (ELV) stake by 37% in Q2 2026, buying an estimated $206K and bringing the position to 2,052 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #577.

Hantz Financial Services first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hantz Financial Services held 2,052 shares of Elevance Health worth $794K as of Q2 2026.
  • Hantz Financial Services bought 555 Elevance Health shares in Q2 2026, an estimated $206K.
  • Elevance Health made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #577 holding.
  • Hantz Financial Services first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.